Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0896-2022Class II

C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or citrate plasma) and...

DRG International, Inc. / initiated 2021-12-21 / Terminated

DRG International, Inc. began a recall of C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or citrate plasma) and urine. Catalog # EIA-1293 on . FDA classified it as Class II and gives the reason as "ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0896-2022
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
DRG International, Inc.
Product
C-Peptide ELISA : IVD measurement of C-Peptide in serum, plasma (EDTA-, heparin- or citrate plasma) and urine. Catalog # EIA-1293
Product code
JKD Radioimmunoassay, C-Peptides Of Proinsulin
Reason for recall
ODs of the standards too low(< 0.6 ODmax) may cause invalid runs, delayed patient results are possible
FDA root cause
Under Investigation by firm
Action
DRG issued letter via email on 12/28/21. Letter states reason for recall, health risk and Action to be taken by distributors and end-users: Please check your inventory for the respective lot, stop using these kits immediately and promptly quarantine these products. Only if you faced above mentioned issue of SO OD <1.2, please ask for replacement of the kits that were affected and provide your data. All unused kits of the affected lot will be replaced.Please reply immediately upon checking your stock/use to this notice to confirm. All replies should be received at once OR by January 7th, 2022. We sincerely apologize for the inconvenience this may have caused you and/or your Customer. Reply to email: [email protected] and copy [email protected].
Quantity in commerce
3 Kits
Distribution
NY
Product codes and lots
Lot# / Expiration dates: 20K061 / 2022-06-30 20K071 / 2022-07-31 20K081 / 2022-08-31

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-0896-2022
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-0896-2022Class IITerminatedVoluntary: Firm initiated